05.06.2014 Views

Prevention Guide - Safe Handling of Hazardous Drugs - Irsst

Prevention Guide - Safe Handling of Hazardous Drugs - Irsst

Prevention Guide - Safe Handling of Hazardous Drugs - Irsst

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

10. ADMINISTRATION OF DRUGS<br />

10.3.13.3 The administration device should be equipped with a filter for patient exhalations and<br />

should automatically stop when the patient removes it from his mouth. Otherwise, it can<br />

be equipped with a patient interrupt mechanism. If the device does not stop automatically,<br />

when applicable, the patient can be given instructions regarding how to stop the<br />

nebulization. The patient should be encouraged to do so before calling the staff if he must<br />

remove the mask from his mouth to cough or if the mask becomes disconnected.<br />

10.3.13.4 Unless it is an emergency situation, wait for at least five minutes following the end <strong>of</strong> the<br />

nebulization before interacting with the patient, to ensure that the air inside the cubicle or<br />

tent is free <strong>of</strong> drugs. Wait this length <strong>of</strong> time before entering the cubicle or lifting the sides<br />

<strong>of</strong> the isolation tent. In an emergency situation, workers should stop the nebulization as<br />

soon as possible. Protective equipment must be worn for any intervention inside the tent or<br />

cubicle.<br />

10.3.13.5 Workers should not remain in the room during drug administration, except when the<br />

patient requires assistance. A visual (viewing window in the door) and/or vocal means <strong>of</strong><br />

communication should allow remote monitoring <strong>of</strong> the patient.<br />

10.3.13.6 If the drug is not administered in a cubicle or tent, workers must put on a N-95 respirator<br />

and goggles before entering the room.<br />

10.3.13.7 Protective equipment (N-95 respirators, gloves, gowns and goggles) must be worn when<br />

handling the nebulizer and in situations where there is a high exposure risk (significant<br />

patient cough, accidental disconnection, uncooperative patient, lifting <strong>of</strong> the sides <strong>of</strong> the<br />

tent or entry into the cubicle).<br />

10.3.13.8 The room should not be cleaned with dry equipment – mops and cleaning cloths should be<br />

damp. The room surfaces should be easy to clean and disinfect.<br />

10.3.13.9 Pregnant workers should not work in areas where pentamidine and ribavirin are present.<br />

10.3.13.10 Every precaution should be taken to limit the exposure <strong>of</strong> health care pr<strong>of</strong>essionals to<br />

hazardous drugs. Thus, the Pharmacy Department should prepare the unit doses <strong>of</strong><br />

hazardous drugs in aerosol form in a preparation cabinet (e.g. SPAG-2). In the event that<br />

this is not possible, the worker preparing the unit doses must wear protective equipment<br />

(N-95 respirator, gloves, gown, face shield or goggles (see 4.1.7.10)).<br />

Pentamidine (additional measures)<br />

10.3.13.11 Measures must be taken to prevent the transmission <strong>of</strong> tuberculosis.<br />

<br />

ONS, p. 26 ♦ OSHA, Sections Vc2d, Appendix VI 2-2<br />

10.3.14 Intrathecal Administration RATING: ++<br />

Use an administration technique that limits exposure risks.<br />

RECOMMENDATIONS<br />

NOTE<br />

The recommendations applicable to the General Administration Measures Section (i.e.,<br />

Section 10.3.4) should be complied with.<br />

10.3.14.1 Workers administering the drugs should use handling and administration techniques that<br />

minimize exposure risks:<br />

‣ wear a gown, one pair <strong>of</strong> gloves (see 4.1.7.7) and face protection (see 4.1.7.10) ;<br />

‣ use syringes and other devices with a Luer-Lock tip; fill the syringe no more than ¾<br />

full;<br />

‣ place a disposable, absorbent, plastic-backed pad under the injection site for the<br />

PREVENTION GUIDE – SAFE HANDLING OF HAZARDOUS DRUGS ASSTSAS 10-15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!